|
1
|
Herrada AA, Escobedo N, Iruretagoyena M,
Valenzuela RA, Burgos PI, Cuitino L and Llanos C: Innate immune
cells' contribution to systemic lupus erythematosus. Front Immunol.
10(772)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Luo Q, Li X, Xu C, Zeng L, Ye J, Guo Y,
Huang Z and Li J: Integrative analysis of long non-coding RNAs and
messenger RNA expression profiles in systemic lupus erythematosus.
Mol Med Rep. 17:3489–3496. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Huang HT, Chen JM, Guo J, Lan Y and Wei
YS: The association of interleukin-31 polymorphisms with
interleukin-31 serum levels and risk of systemic lupus
erythematosus. Rheumatol Int. 36:799–805. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wenderfer SE and Eldin KW: Lupus
nephritis. Pediatr Clin North Am. 66:87–99. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Thomas G, Mancini J, Jourde-Chiche N,
Sarlon G, Amoura Z, Harlé JR, Jougla E and Chiche L: Mortality
associated with systemic lupus erythematosus in france assessed by
multiple-cause-of-death analysis. Arthritis Rheumatol.
66:2503–2511. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Troldborg A, Jensen L, Deleuran B,
Stengaard-Pedersen K, Thiel S and Jensenius JC: The C3dg fragment
of complement is superior to conventional C3 as a diagnostic
biomarker in systemic lupus erythematosus. Front Immunol.
9(581)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mulvihill E, Ardoin S, Thompson SD, Zhou
B, Yu GR, King E, Singer N, Levy DM, Brunner H, Wu YL, et al:
Elevated serum complement levels and higher gene copy number of
complement C4B are associated with hypertension and effective
response to statin therapy in childhood-onset systemic lupus
erythematosus (SLE). Lupus Sci Med. 6(e000333)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Qu C, Zhang J, Zhang X, Du J, Su B and Li
H: Value of combined detection of anti-nuclear antibody,
anti-double-stranded DNA antibody and C3, C4 complements in the
clinical diagnosis of systemic lupus erythematosus. Exp Ther Med.
17:1390–1394. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lekka E and Hall J: Noncoding RNAs in
disease. FEBS Lett. 592:2884–2900. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tian J, An X and Niu L: Role of microRNAs
in cardiac development and disease. Exp Ther Med. 13:3–8.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhou Q, Yu Q, Gong Y, Liu Z, Xu H, Wang Y
and Shi Y: Construction of a lncRNA-miRNA-mRNA network to determine
the regulatory roles of lncRNAs in psoriasis. Exp Ther Med.
18:4011–4021. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Guttman M, Amit I, Garber M, French C, Lin
MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, et al:
Chromatin signature reveals over a thousand highly conserved large
non-coding RNAs in mammals. Nature. 458:223–227. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Messemaker TC, Frank-Bertoncelj M, Marques
RB, Adriaans A, Bakker AM, Daha N, Gay S, Huizinga TW, Toes REM,
Mikkers HMM and Kurreeman F: A novel long non-coding RNA in the
rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levels.
Genes Immun. 17:85–92. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yi R, Yang L, Zeng S and Su Y: Different
expression profile of mRNA and long noncoding RNA in autoimmune
thyroid diseases patients. J Cell Biochem. 120:19442–19456.
2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wu Y, Zhang F, Ma J, Zhang X, Wu L, Qu B,
Xia S, Chen S, Tang Y and Shen N: Association of large intergenic
noncoding RNA expression with disease activity and organ damage in
systemic lupus erythematosus. Arthritis Res Ther.
17(131)2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zheng CZ, Yan WW, Luo YL, Wang TL and Shu
YB: Value of sTNF-R1 and linc0597 as indicators for disease
activity and diagnosis of lupus nephritis. Eur Rev Med Pharmacol
Sci. 24:5582–5591. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wu GC, Li J, Leng RX, Li XP, Li XM, Wang
DG, Pan HF and Ye DQ: Identification of long non-coding RNAs GAS5,
linc0597 and lnc-DC in plasma as novel biomarkers for systemic
lupus erythematosus. Oncotarget. 8:23650–23663. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li Z, Chao TC, Chang KY, Lin N, Patil VS,
Shimizu C, Head SR, Burns JC and Rana TM: The long noncoding RNA
THRIL regulates TNF expression through its interaction with hnRNPL.
Proc Natl Acad Sci USA. 111:1002–1007. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yuan S, Tang C, Chen D, Li F, Huang M, Ye
J, He Z, Li W, Chen Y, Lin X, et al: miR-98 modulates cytokine
production from human PBMCs in systemic lupus erythematosus by
targeting IL-6 mRNA. J Immunol Res. 2019(9827574)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hochberg MC: Updating the American college
of rheumatology revised criteria for the classification of systemic
lupus erythematosus. Arthritis Rheum. 40(1725)1997.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Aletaha D, Neogi T, Silman AJ, Funovits J,
Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP,
Cohen MD, et al: 2010 rheumatoid arthritis classification criteria:
An American college of Rheumatology/European league against
rheumatism collaborative initiative. Arthritis Rheum. 69:1580–1588.
2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Vitali C, Bombardieri S, Jonsson R,
Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox
RI, Kassan SS, et al: Classification criteria for sjögren's
syndrome: A revised version of the European criteria proposed by
the American-European consensus group. Ann Rheum Dis. 61:554–558.
2002.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tong YS, Wang XW, Zhou XL, Liu ZH, Yang
TX, Shi WH, Xie HW, Lv J, Wu QQ and Cao XF: Identification of the
long non-coding RNA POU3F3 in plasma as a novel biomarker for
diagnosis of esophageal squamous cell carcinoma. Mol Cancer.
14(3)2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhao CN, Mao YM, Liu LN, Li XM, Wang DG
and Pan HF: Emerging role of lncRNAs in systemic lupus
erythematosus. Biomed Pharmacother. 106:584–592. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wu GC, Hu Y, Guan SY, Ye DQ and Pan HF:
Differential plasma expression profiles of long non-Coding RNAs
reveal potential biomarkers for systemic lupus erythematosus.
Biomolecules. 9(206)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Song X, Rui C, Meng L, Zhang R, Shen R,
Ding H, Li J, Li J and Long W: Long non-coding RNA RPAIN regulates
the invasion and apoptosis of trophoblast cell lines via complement
protein C1q. Oncotarget. 8:7637–7646. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang Q, Liang Y, Yuan H, Li S, Wang JB,
Li XM, Tao JH, Pan HF and Ye DQ: Integrated analysis of lncRNA,
miRNA and mRNA expression profiling in patients with systemic lupus
erythematosus. Arch Med Sci. 15:872–879. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Müller N, Döring F, Klapper M, Neumann K,
Schulte DM, Türk K, Schröder JO, Zeuner RA, Freitag-Wolf S,
Schreiber S and Laudes M: Interleukin-6 and tumour necrosis
factor-α differentially regulate lincRNA transcripts in cells of
the innate immune system in vivo in human subjects with rheumatoid
arthritis. Cytokine. 68:65–68. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J,
Wei M, Xu C, Wu C, Zhang Z, et al: Long non-coding RNA metastasis
associated in lung adenocarcinoma transcript 1 derived miniRNA as a
novel plasma-based biomarker for diagnosing prostate cancer. Eur J
Cancer. 49:2949–2959. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cabili MN, Trapnell C, Goff L, Koziol M,
Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human
large intergenic noncoding RNAs reveals global properties and
specific subclasses. Genes Dev. 25:1915–1927. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kawai T and Akira S: The role of
pattern-recognition receptors in innate immunity: Update on
toll-like receptors. Nat Immunol. 11:373–384. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Blasius AL and Beutler B: Intracellular
toll-like receptors. Immunity. 32:305–315. 2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cansu DÜ, Temiz G, Açıkalın MF and Korkmaz
C: Pauci-immune lupus nephritis: Possibility or co-incidence? Eur J
Rheumatol. 4:73–75. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Haładyj E and Cervera R: Do we still need
renal biopsy in lupus nephritis? Reumatologia. 54:61–66.
2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Chaichian Y, Wallace DJ and Weisman MH: A
promising approach to targeting type 1 IFN in systemic lupus
erythematosus. J Clin Invest. 129:958–961. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Murayama G, Furusawa N, Chiba A, Yamaji K,
Tamura N and Miyake S: Enhanced IFN-α production is associated with
increased TLR7 retention in the lysosomes of palasmacytoid
dendritic cells in systemic lupus erythematosus. Arthritis Res
Ther. 19(234)2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Higgs BW, Liu Z, White B, Zhu W, White WI,
Morehouse C, Brohawn P, Kiener PA, Richman L, Fiorentino D, et al:
Patients with systemic lupus erythematosus, myositis, rheumatoid
arthritis and scleroderma share activation of a common type I
interferon pathway. Ann Rheum Dis. 70:2029–2036. 2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bodewes ILA, Huijser E, van
Helden-Meeuwsen CG, Tas L, Huizinga R, Dalm V, van Hagen PM, Groot
N, Kamphuis S, van Daele PLA and Versnel MA: TBK1: A key regulator
and potential treatment target for interferon positive sjögren's
syndrome, systemic lupus erythematosus and systemic sclerosis. J
Autoimmun. 91:97–102. 2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Luo Q, Xu C, Li X, Zeng L, Ye J, Guo Y,
Huang Z and Li J: Comprehensive analysis of long non-coding RNA and
mRNA expression profiles in rheumatoid arthritis. Exp Ther Med.
14:5965–5973. 2017.PubMed/NCBI View Article : Google Scholar
|
